Safety of the intravenous administration of neurotensin-polyplex nanoparticles in BALB/c mice
dc.contributor.author | Hernandez, Maria | |
dc.contributor.author | Rembao, Jesus | |
dc.contributor.author | Hernandez-Baltazar, Daniel | |
dc.contributor.author | Castillo-Rodriguez, Rosa | |
dc.contributor.author | Tellez-Lopez, Victor | |
dc.contributor.author | Flores-Martinez, Yazmin | |
dc.date.accessioned | 2017-03-13T19:54:17Z | |
dc.date.available | 2017-03-13T19:54:17Z | |
dc.date.issued | 2014 | |
dc.description | Centro de Medicina Regenerativa | |
dc.description.abstract | Neurotensin (NTS)-polyplex is a gene nanocarrier that has potential nanomedicine-based applications for the treatment of Parkinson's disease and cancers of cells expressing NTS receptor type 1. We assessed the acute inflammatory response to NTS-polyplex carrying a reporter gene in BALB/c mice. The intravenous injection of NTS-polyplex caused the specific expression of the reporter gene in gastrointestinal cells. Six hours after an intravenous injection of propidium iodide labeled-NTS-polyplex, fluorescent spots were located in the cells of the organs with a mononuclear phagocyte system, suggesting NTS-polyplex clearance. In contrast to lipopolysaccharide and carbon tetrachloride, NTS-polyplex did not increase the serum levels of tumor necrosis factor alpha, interleukin (IL)-1β, IL-6, bilirubin, aspartate transaminase, and alanine transaminase. NTS-polyplex increased the levels of serum amyloid A and alkaline phosphatase, but these levels normalized after 24 h. Compared to carrageenan, the local injection of NTS-polyplex did not produce inflammation. Our results support the safety of NTS-polyplex. | |
dc.format.extent | 10 | |
dc.identifier.citation | Nanomedicine. 2014 May;10(4):745-54 | |
dc.identifier.uri | http://hdl.handle.net/11447/1020 | |
dc.identifier.uri | http://dx.doi.org/10.1016/j.nano.2013.11.013 | |
dc.language.iso | en_US | |
dc.publisher | Future Medicine | |
dc.subject | Biosafety | |
dc.subject | Cytotoxicity | |
dc.subject | Nanomaterials | |
dc.subject | Pro-inflammatory cytokines | |
dc.title | Safety of the intravenous administration of neurotensin-polyplex nanoparticles in BALB/c mice | |
dc.type | Artículo |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Safety of the intravenous administration of neurotensin-polyplex nanoparticles in BALBc mice.pdf
- Size:
- 1.8 MB
- Format:
- Adobe Portable Document Format
- Description:
- Texto completo